In particular, the results obtained in the fibrosarcoma model show that neutralization of endogenous CgA with specific antibodies enhances tumor growth rate, whereas systemic administration of low amounts of exogenous full-length CgA reduces tumor growth. This evidence concerns the gene CGA and neoplasm.